Literature DB >> 18603588

The unfolding of alpha-momorcharin proceeds through the compact folded intermediate.

Yukihiro Fukunaga1, Etsuko Nishimoto, Takuhiro Otosu, Yasutaka Murakami, Shoji Yamashita.   

Abstract

The unfolding of alpha-momorcharin was systematically investigated using steady-state and time-resolved tryptophan fluorescence, circular dichroism and 8-anilino-1-naphthalenesulfonic acid (ANS) binding. These spectroscopic studies demonstrated that alpha-momorcharin unfolded through a compact folded intermediate state. The content of alpha-helix was increased, Trp192 approached closer to the side of active site and its rotational motion was restricted by being equilibrated with 2-3 M of guanidine hydrochloride. Furthermore, the binding of ANS with alpha-momorcharin was more suppressed to show that the hydrophobic parts would not be accessed to the protein surface but rather be sealed off in this specific conformation state. These results suggest that the structure of alpha-momorcharin holds the more compact conformation as an incipient state for unfolding, which is the sharp contrast to beta-momorcharin that gives the characteristics of the generally known molten globule state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603588     DOI: 10.1093/jb/mvn088

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

1.  Structural characteristic of folding/unfolding intermediate of pokeweed anti-viral protein revealed by time-resolved fluorescence.

Authors:  Shuzo Matsumoto; Yuka Taniguchi; Yukihiro Fukunaga; Hiromichi Nakashima; Keiichi Watanabe; Shoji Yamashita; Etsuko Nishimoto
Journal:  J Fluoresc       Date:  2013-01-15       Impact factor: 2.217

2.  A Spectroscopic Study on Secondary Structure and Thermal Unfolding of the Plant Toxin Gelonin Confirms Some Typical Structural Characteristics and Unravels the Sequence of Thermal Unfolding Events.

Authors:  Andrea Scirè; Fabio Tanfani; Alessio Ausili
Journal:  Toxins (Basel)       Date:  2019-08-22       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.